Premium
This is an archive article published on October 25, 2012

HSBC upgrades Lupin shares

HSBC also raised its target price to 650 rupees from 640 rupees.

HSBC upgraded Lupin to 8216;overweight8217; from 8216;neutral8217;,saying the drug maker8217;s July-September earnings were higher than expected,while shares had under-performed peers over the past three months.

HSBC also raised its target price to 650 rupees from 640 rupees,adding Lupin is seeing healthy sales across regions,while highlighting near-term launches in the drug maker8217;s U.S. pipeline.

The drug maker on Tuesday said its July-September quarter net profit rose 9 percent to 2.91 billion rupees 54.32 million.

Lupin shares fell 0.3 percent to 561.15 rupees at 0348 GMT.

 

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement